737 related articles for article (PubMed ID: 17075851)
1. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
2. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
Garnero P; Aronstein WS; Cohen SB; Conaghan PG; Cline GA; Christiansen C; Beary JF; Meyer JM; Bingham CO
Osteoarthritis Cartilage; 2008 Jun; 16(6):660-6. PubMed ID: 17993283
[TBL] [Abstract][Full Text] [Related]
3. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].
Spector TD; Conaghan PG; Buckland-Wright JC; Garnero P; Cline GA; Beary JF; Valent DJ; Meyer JM
Arthritis Res Ther; 2005; 7(3):R625-33. PubMed ID: 15899049
[TBL] [Abstract][Full Text] [Related]
4. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients.
Buckland-Wright JC; Messent EA; Bingham CO; Ward RJ; Tonkin C
Rheumatology (Oxford); 2007 Feb; 46(2):257-64. PubMed ID: 16837470
[TBL] [Abstract][Full Text] [Related]
5. Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees.
Mazzuca SA; Brandt KD; Lane KA; Katz BP
Arthritis Rheum; 2002 May; 46(5):1223-7. PubMed ID: 12115227
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.
Bruyere O; Collette JH; Ethgen O; Rovati LC; Giacovelli G; Henrotin YE; Seidel L; Reginster JY
J Rheumatol; 2003 May; 30(5):1043-50. PubMed ID: 12734904
[TBL] [Abstract][Full Text] [Related]
7. Effects of risedronate on osteoarthritis of the knee.
Iwamoto J; Takeda T; Sato Y; Matsumoto H
Yonsei Med J; 2010 Mar; 51(2):164-70. PubMed ID: 20191005
[TBL] [Abstract][Full Text] [Related]
8. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.
Martel-Pelletier J; Roubille C; Abram F; Hochberg MC; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Ann Rheum Dis; 2015 Mar; 74(3):547-56. PubMed ID: 24336337
[TBL] [Abstract][Full Text] [Related]
9. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
Karsdal MA; Byrjalsen I; Alexandersen P; Bihlet A; Andersen JR; Riis BJ; Bay-Jensen AC; Christiansen C;
Osteoarthritis Cartilage; 2015 Apr; 23(4):532-43. PubMed ID: 25582279
[TBL] [Abstract][Full Text] [Related]
10. Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis.
Mazzuca SA; Brandt KD; Schauwecker DS; Katz BP; Meyer JM; Lane KA; Bradley JD; Hugenberg ST; Wolfe F; Moreland LW; Heck LW; Yocum DE; Schnitzer TJ; Sharma L; Manzi S; Oddis CV
J Rheumatol; 2005 Aug; 32(8):1540-6. PubMed ID: 16078332
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.
Kahan A; Uebelhart D; De Vathaire F; Delmas PD; Reginster JY
Arthritis Rheum; 2009 Feb; 60(2):524-33. PubMed ID: 19180484
[TBL] [Abstract][Full Text] [Related]
12. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.
Deberg MA; Labasse AH; Collette J; Seidel L; Reginster JY; Henrotin YE
Osteoarthritis Cartilage; 2005 Dec; 13(12):1059-65. PubMed ID: 16154771
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.
Raynauld JP; Buckland-Wright C; Ward R; Choquette D; Haraoui B; Martel-Pelletier J; Uthman I; Khy V; Tremblay JL; Bertrand C; Pelletier JP
Arthritis Rheum; 2003 Feb; 48(2):370-7. PubMed ID: 12571845
[TBL] [Abstract][Full Text] [Related]
15. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
[TBL] [Abstract][Full Text] [Related]
16. OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
Karsdal MA; Bihlet A; Byrjalsen I; Alexandersen P; Ladel C; Michaels M; Andersen JR; Riis BJ; Kraus V; Bay-Jensen AC; Christiansen C
Osteoarthritis Cartilage; 2015 Apr; 23(4):550-8. PubMed ID: 25576879
[TBL] [Abstract][Full Text] [Related]
17. Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis.
Bartlett SJ; Ling SM; Mayo NE; Scott SC; Bingham CO
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1722-8. PubMed ID: 21905250
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
Garnero P; Peterfy C; Zaim S; Schoenharting M
Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
[TBL] [Abstract][Full Text] [Related]
19. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.
Laslett LL; Kingsbury SR; Hensor EM; Bowes MA; Conaghan PG
Ann Rheum Dis; 2014 May; 73(5):824-30. PubMed ID: 23585518
[TBL] [Abstract][Full Text] [Related]
20. A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
Aitken D; Laslett LL; Cai G; Hill C; March L; Wluka AE; Wang Y; Blizzard L; Cicuttini F; Jones G
BMC Musculoskelet Disord; 2018 Jul; 19(1):217. PubMed ID: 30021646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
